Second patient dies during clinical trial for obesity drug
Wednesday, December 2, 2015 - 11:55
in Health & Medicine
Stephen FellerWASHINGTON, Dec. 2 (UPI) -- A second patient has died in a clinical trial for the drug beloranib, which is being tested for use with a rare obesity disorder called Prader-Willi syndrome.